(Q36381003)

13 August 2017

1 reference

title

Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. (English)

1 reference

13 August 2017

1 reference

1 reference

Karsten Sydow

1

1 reference

PubMed ID

16444867

13 August 2017

Carl E Mondon

series ordinal

2

1 reference

PubMed ID

16444867

13 August 2017

John P Cooke

series ordinal

3

1 reference

13 August 2017

1 July 2005

1 reference

13 August 2017

1 reference

13 August 2017

10 Suppl 1

1 reference

13 August 2017

S35-43

1 reference

Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers

13 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Asymmetrical dimethylarginine: the Uber marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Differentiation between obesity and insulin resistance in the association with C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Hypertension in mice lacking the gene for endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Coronary vasomotor abnormalities in insulin-resistant individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Insulin and blood pressure in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Insulinemia and blood pressure. Relationships in patients with primary and secondary hypertension, and with or without glucose metabolism impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Insulin-induced vasodilatation: physiology or pharmacology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Effect of Insulin on Acetylcholine-Induced Vasodilation in Normotensive Subjects and Patients With Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Evidence that nitric oxide increases glucose transport in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Effects of sympathectomy and nitric oxide synthase inhibition on vascular actions of insulin in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Nitric oxide release accounts for insulin's vascular effects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Nitric oxide as a signal in blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Role of blood flow in the regulation of muscle glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Metformin improves vascular function in insulin-resistant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Improved endothelial function with metformin in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting serum insulin concentration and glucose tolerance in 48-year-old men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Kinetics of insulin action in vivo. Identification of rate-limiting steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM604OA

10.1191/1358863X05VM604OA

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16444867